Sandoz Makes Major Moves To Bolster Biosimilars Ahead Of Spinoff

Announces Development Partnership With Evotec And Investment In Holzkirchen Site

May 10 2023

Sandoz is building up its biosimilars business before spinning off from Novartis • Source: Shutterstock